EMEA (Europe, Middle East and Africa) Urokinase Market 2017 Forecast to 2022

EMEA (Europe, Middle East and Africa) Urokinase Market 2017 Forecast to 2022

Published by: GIR (Global Info Research)
Catalog: Pharmaceuticals
Publishing Date:  Nov 2017
Single User License: USD 4480
Corporate Users License: USD 8960
Delivery time: 48 hours
Pages: 124
Tables and Figures: 139
Contact: Tel: 00852-58197708 (HK); Email: sales@globalinforesearch.com

Description
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.


Scope of the Report:
This report focuses on the Urokinase in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
    NDPharm
    Wanhua Biochem
    Jiangxi Haoran Bio-Pharma
    Jiangsu Aidea Pharmaceutical

Market Segment by Regions, regional analysis covers
    Europe (Germany, France, UK, Russia, Italy and Turkey)
    Middle East (Saudi Arabia, Israel, UAE and Iran)
    Africa (South Africa, Nigeria, Egypt and Algeria)

Market Segment by Type, covers
    Urokinase Powder
    Urokinase Solution

Market Segment by Applications, can be divided into
    Hospital
    Clinic
    Others

There are 13 Chapters to deeply display the EMEA Urokinase market.

Chapter 1, to describe Urokinase Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Urokinase, with sales, revenue, and price of Urokinase, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of Urokinase, for each region, from 2012 to 2017;

Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions;

Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 10, Urokinase market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 11, 12 and 13, to describe Urokinase research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source


Table of Contents
1 Market Overview
    1.1 Urokinase Introduction
    1.2 Market Analysis by Type
        1.2.1 Urokinase Powder
        1.2.2 Urokinase Solution
    1.3 Market Analysis by Applications
        1.3.1 Hospital
        1.3.2 Clinic
        1.3.3 Others
    1.4 Market Analysis by Regions
        1.4.1 Europe (Germany, France, UK, Italy, Russia and Turkey)
            1.4.1.1 Germany Market States and Outlook (2012-2022)
            1.4.1.2 France Market States and Outlook (2012-2022)
            1.4.1.3 UK Market States and Outlook (2012-2022)
            1.4.1.4 Italy Market States and Outlook (2012-2022)
            1.4.1.5 Russia Market States and Outlook (2012-2022)
            1.4.1.6 Turkey Market States and Outlook (2012-2022)
        1.4.2 Middle East (Saudi Arabia, Israel, UAE and Iran)
            1.4.2.1 Saudi Arabia Market States and Outlook (2012-2022)
            1.4.2.2 UAE Market States and Outlook (2012-2022)
            1.4.2.3 Israel Market States and Outlook (2012-2022)
            1.4.2.4 Iran Market States and Outlook (2012-2022)
        1.4.3 Africa (South Africa, Nigeria, Egypt and Algeria)
            1.4.3.1 South Africa Market States and Outlook (2012-2022)
            1.4.3.2 Nigeria Market States and Outlook (2012-2022)
            1.4.3.3 Egypt Market States and Outlook (2012-2022)
            1.4.3.4 Algeria Market States and Outlook (2012-2022)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 NDPharm
        2.1.1 Business Overview
        2.1.2 Urokinase Type and Applications
            2.1.2.1 Type 1
            2.1.2.2 Type 2
        2.1.3 NDPharm Urokinase Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2 Wanhua Biochem
        2.2.1 Business Overview
        2.2.2 Urokinase Type and Applications
            2.2.2.1 Type 1
            2.2.2.2 Type 2
        2.2.3 Wanhua Biochem Urokinase Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3 Jiangxi Haoran Bio-Pharma
        2.3.1 Business Overview
        2.3.2 Urokinase Type and Applications
            2.3.2.1 Type 1
            2.3.2.2 Type 2
        2.3.3 Jiangxi Haoran Bio-Pharma Urokinase Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4 Jiangsu Aidea Pharmaceutical
        2.4.1 Business Overview
        2.4.2 Urokinase Type and Applications
            2.4.2.1 Type 1
            2.4.2.2 Type 2
        2.4.3 Jiangsu Aidea Pharmaceutical Urokinase Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 EMEA Urokinase Market Competition, by Manufacturer
    3.1 EMEA Urokinase Sales and Market Share by Manufacturer
    3.2 EMEA Urokinase Revenue and Market Share by Manufacturer
    3.3 EMEA Urokinase Price by Manufacturer (2016-2017)
    3.4 Market Concentration Rate
        3.4.1 Top 3 Urokinase Manufacturer Market Share
        3.4.2 Top 5 Urokinase Manufacturer Market Share
    3.5 Market Competition Trend
4 EMEA Urokinase Market Analysis by Regions
    4.1 EMEA Urokinase Sales, Revenue and Market Share by Regions
        4.1.1 EMEA Urokinase Sales by Regions (2012-2017)
        4.1.2 EMEA Urokinase Revenue by Regions (2012-2017)
    4.2 Europe Urokinase Sales and Growth (2012-2017)
    4.3 Middle East Urokinase Sales and Growth (2012-2017)
    4.4 Africa Urokinase Sales and Growth (2012-2017)
5 Europe Urokinase by Countries, Type, Application and Manufacturers
    5.1 Europe Urokinase Sales, Revenue and Market Share by Countries
        5.1.1 Europe Urokinase Sales by Countries (2012-2017)
        5.1.2 Europe Urokinase Revenue by Countries (2012-2017)
        5.1.3 Germany Urokinase Sales and Growth (2012-2017)
        5.1.4 France Urokinase Sales and Growth (2012-2017)
        5.1.5 UK Urokinase Sales and Growth (2012-2017)
        5.1.6 Russia Urokinase Sales and Growth (2012-2017)
        5.1.7 Italy Urokinase Sales and Growth (2012-2017)
        5.1.8 Turkey Urokinase Sales and Growth (2012-2017)
    5.2 Europe Urokinase Sales and Revenue (value) by Manufacturers (2016-2017)
        5.2.1 Europe Urokinase Sales by Manufacturers (2016-2017)
        5.2.2 Europe Urokinase Revenue by Manufacturers (2016-2017)
    5.3 Europe Urokinase Sales by Type (2012-2017)
    5.4 Europe Urokinase Sales by Application (2012-2017)
6 Middle East Urokinase by Countries, Type, Application and Manufacturers
    6.1 Middle East Urokinase Sales, Revenue and Market Share by Countries
        6.1.1 Middle East Urokinase Sales by Countries (2012-2017)
        6.1.2 Middle East Urokinase Revenue by Countries (2012-2017)
        6.1.3 Saudi Arabia Urokinase Sales and Growth (2012-2017)
        6.1.4 Israel Urokinase Sales and Growth (2012-2017)
        6.1.5 UAE Urokinase Sales and Growth (2012-2017)
        6.1.6 Iran Urokinase Sales and Growth (2012-2017)
    6.2 Middle East Urokinase Sales and Revenue (value) by Manufacturers (2016-2017)
        6.2.1 Middle East Urokinase Sales by Manufacturers (2016-2017)
        6.2.2 Middle East Urokinase Revenue by Manufacturers (2016-2017)
    6.3 Middle East Urokinase Sales by Type (2012-2017)
    6.4 Middle East Urokinase Sales by Application (2012-2017)
7 Africa Urokinase by Countries, Type, Application and Manufacturers
    7.1 Africa Urokinase Sales, Revenue and Market Share by Countries
        7.1.1 Africa Urokinase Sales by Countries (2012-2017)
        7.1.2 Africa Urokinase Revenue by Countries (2012-2017)
        7.1.3 South Africa Urokinase Sales and Growth (2012-2017)
        7.1.4 Nigeria Urokinase Sales and Growth (2012-2017)
        7.1.5 Egypt Urokinase Sales and Growth (2012-2017)
        7.1.6 Algeria Urokinase Sales and Growth (2012-2017)
    7.2 Middle East Urokinase Sales and Revenue (value) by Manufacturers (2016-2017)
        7.2.1 Middle East Urokinase Sales by Manufacturers (2016-2017)
        7.2.2 Middle East Urokinase Revenue by Manufacturers (2016-2017)
    7.3 Middle East Urokinase Sales by Type (2012-2017)
    7.4 Middle East Urokinase Sales by Application (2012-2017)
8 EMEA Urokinase Market Segment by Type
    8.1 EMEA Urokinase Sales, Revenue and Market Share by Type (2012-2017)
        8.1.1 EMEA Urokinase Sales and Market Share by Type (2012-2017)
        8.1.2 EMEA Urokinase Revenue and Market Share by Type (2012-2017)
    8.2 Urokinase Powder Sales Growth and Price
        10.2.1 EMEA Urokinase Powder Sales Growth (2012-2017)
        10.2.2 EMEA Urokinase Powder Price (2012-2017)
    8.3 Urokinase Solution Sales Growth and Price
        10.3.1 EMEA Urokinase Solution Sales Growth (2012-2017)
        10.3.2 EMEA Urokinase Solution Price (2012-2017)
9 EMEA Urokinase Market Segment by Application
    9.1 EMEA Urokinase Sales Market Share by Application (2012-2017)
    9.2 Hospital Sales Growth (2012-2017)
    9.3 Clinic Sales Growth (2012-2017)
    9.4 Others Sales Growth (2012-2017)
10 EMEA Urokinase Market Forecast (2017-2022)
    10.1 EMEA Urokinase Sales, Revenue and Growth Rate (2017-2022)
    10.2 Urokinase Market Forecast by Regions (2017-2022)
        10.2.1 Europe Urokinase Market Forecast by Regions (2017-2022)
            10.2.1.1 Germany Urokinase Sales Forecast 2017-2022
            10.2.1.2 France Urokinase Sales Forecast 2017-2022
            10.2.1.3 UK Urokinase Sales Forecast 2017-2022
            10.2.1.4 Russia Urokinase Sales Forecast 2017-2022
            10.2.1.5 Italy Urokinase Sales Forecast 2017-2022
            10.2.1.6 Turkey Urokinase Sales Forecast 2017-2022
        10.2.2 Middle East Market Forecast by Regions (2017-2022)
            10.2.2.1 Saudi Arabia Urokinase Sales Forecast 2017-2022
            10.2.2.2 Israel Urokinase Sales Forecast 2017-2022
            10.2.2.3 UAE Urokinase Sales Forecast 2017-2022
            10.2.2.4 Iran Urokinase Sales Forecast 2017-2022
        10.2.3 Africa Market Forecast by Regions (2017-2022)
            10.2.3.1 South Africa Urokinase Sales Forecast 2017-2022
            10.2.3.2 Nigeria Urokinase Sales Forecast 2017-2022
            10.2.3.3 Egypt Urokinase Sales Forecast 2017-2022
            10.2.3.4 Algeria Urokinase Sales Forecast 2017-2022
    10.3 Urokinase Market Forecast by Type (2017-2022)
    10.4 Urokinase Market Forecast by Application (2017-2022)
11 Sales Channel, Distributors, Traders and Dealers
    11.1 Sales Channel
        11.1.1 Direct Marketing
        11.1.2 Indirect Marketing
        11.1.3 Marketing Channel Future Trend
    11.2 Distributors, Traders and Dealers
12 Research Findings and Conclusion
13 Appendix
    13.1 Methodology
    13.2 Analyst Introduction
    13.3 Data Source


List of Tables and Figures

Figure Urokinase Picture
Table Product Specifications of Urokinase
Figure EMEA Sales Market Share of Urokinase by Types in 2016
Table Urokinase Types for Major Manufacturers
Figure Urokinase Powder Picture
Figure Urokinase Solution Picture
Table Urokinase Sales Market Share by Applications in 2016
Figure Hospital Picture
Figure Clinic Picture
Figure Others Picture
Figure Germany Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure France Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure UK Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure Turkey Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure UAE Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure Israel Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure Iran Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure Algeria Urokinase Revenue (Value) and Growth Rate (2012-2022)
Table NDPharm Basic Information, Manufacturing Base and Competitors
Table NDPharm Urokinase Type and Applications
Table NDPharm Urokinase Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Wanhua Biochem Basic Information, Manufacturing Base and Competitors
Table Wanhua Biochem Urokinase Type and Applications
Table Wanhua Biochem Urokinase Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Jiangxi Haoran Bio-Pharma Basic Information, Manufacturing Base and Competitors
Table Jiangxi Haoran Bio-Pharma Urokinase Type and Applications
Table Jiangxi Haoran Bio-Pharma Urokinase Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Jiangsu Aidea Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Jiangsu Aidea Pharmaceutical Urokinase Type and Applications
Table Jiangsu Aidea Pharmaceutical Urokinase Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table EMEA Urokinase Sales by Manufacturer (2016-2017)
Figure EMEA Urokinase Sales Market Share by Manufacturer in 2016
Figure EMEA Urokinase Sales Market Share by Manufacturer in 2017
Table EMEA Urokinase Revenue by Manufacturer (2016-2017)
Figure EMEA Urokinase Revenue Market Share by Manufacturer in 2016
Figure EMEA Urokinase Revenue Market Share by Manufacturer in 2017
Table EMEA Urokinase Price by Manufacturer (2016-2017)
Figure EMEA Urokinase Sales and Growth (2012-2017)
Figure EMEA Urokinase Revenue and Growth (2012-2017)
Table EMEA Urokinase Sales by Regions (2012-2017)
Table EMEA Urokinase Sales Market Share by Regions (2012-2017)
Figure EMEA Urokinase Sales Market Share by Regions in 2012
Figure EMEA Urokinase Sales Market Share by Regions in 2016
Table EMEA Urokinase Revenue by Regions (2012-2017)
Table EMEA Urokinase Revenue Market Share by Regions (2012-2017)
Figure EMEA Urokinase Revenue Market Share by Regions in 2012
Figure EMEA Urokinase Revenue Market Share by Regions in 2016
Figure Europe Urokinase Sales and Growth (2012-2017)
Figure Middle East Urokinase Sales and Growth (2012-2017)
Figure Africa Urokinase Sales and Growth (2012-2017)
Figure Europe Urokinase Revenue and Growth (2012-2017)
Table Europe Urokinase Sales by Countries (2012-2017)
Table Europe Urokinase Sales Market Share by Countries (2012-2017)
Figure Europe Urokinase Sales Market Share by Countries in 2012
Figure Europe Urokinase Sales Market Share by Countries in 2016
Table Europe Urokinase Revenue by Countries (2012-2017)
Table Europe Urokinase Revenue Market Share by Countries (2012-2017)
Figure Europe Urokinase Revenue Market Share by Countries in 2012
Figure Europe Urokinase Revenue Market Share by Countries in 2016
Figure Germany Urokinase Sales and Growth (2012-2017)
Figure France Urokinase Sales and Growth (2012-2017)
Figure UK Urokinase Sales and Growth (2012-2017)
Figure Russia Urokinase Sales and Growth (2012-2017)
Figure Italy Urokinase Sales and Growth (2012-2017)
Figure Turkey Urokinase Sales and Growth (2012-2017)
Table Europe Urokinase Sales by Manufacturer (2016-2017)
Figure Europe Urokinase Sales Market Share by Manufacturer in 2016
Figure Europe Urokinase Sales Market Share by Manufacturer in 2017
Table Europe Urokinase Revenue by Manufacturer (2016-2017)
Figure Europe Urokinase Revenue Market Share by Manufacturer in 2016
Figure Europe Urokinase Revenue Market Share by Manufacturer in 2017
Table Europe Urokinase Sales by Type (2012-2017)
Table Europe Urokinase Sales Share by Type (2012-2017)
Table Europe Urokinase Sales by Application (2012-2017)
Table Europe Urokinase Sales Share by Application (2012-2017)
Figure Middle East Urokinase Revenue and Growth (2012-2017)
Table Middle East Urokinase Sales by Countries (2012-2017)
Table Middle East Urokinase Sales Market Share by Countries (2012-2017)
Figure Middle East Urokinase Sales Market Share by Countries in 2012
Figure Middle East Urokinase Sales Market Share by Countries in 2016
Table Middle East Urokinase Revenue by Countries (2012-2017)
Table Middle East Urokinase Revenue Market Share by Countries (2012-2017)
Figure Middle East Urokinase Revenue Market Share by Countries in 2012
Figure Middle East Urokinase Revenue Market Share by Countries in 2016
Figure Saudi Arabia Urokinase Sales and Growth (2012-2017)
Figure Israel Urokinase Sales and Growth (2012-2017)
Figure UAE Urokinase Sales and Growth (2012-2017)
Figure Iran Urokinase Sales and Growth (2012-2017)
Table Middle East Urokinase Sales by Manufacturer (2016-2017)
Figure Middle East Urokinase Sales Market Share by Manufacturer in 2016
Figure Middle East Urokinase Sales Market Share by Manufacturer in 2017
Table Middle East Urokinase Revenue by Manufacturer (2016-2017)
Figure Middle East Urokinase Revenue Market Share by Manufacturer in 2016
Figure Middle East Urokinase Revenue Market Share by Manufacturer in 2017
Table Middle East Urokinase Sales by Type (2012-2017)
Table Middle East Urokinase Sales Share by Type (2012-2017)
Table Middle East Urokinase Sales by Application (2012-2017)
Table Middle East Urokinase Sales Share by Application (2012-2017)
Figure Africa Urokinase Revenue and Growth (2012-2017)
Table Africa Urokinase Sales by Countries (2012-2017)
Table Africa Urokinase Sales Market Share by Countries (2012-2017)
Figure Africa Urokinase Sales Market Share by Countries in 2012
Figure Africa Urokinase Sales Market Share by Countries in 2016
Table Africa Urokinase Revenue by Countries (2012-2017)
Table Africa Urokinase Revenue Market Share by Countries (2012-2017)
Figure Africa Urokinase Revenue Market Share by Countries in 2012
Figure Africa Urokinase Revenue Market Share by Countries in 2016
Figure South Africa Urokinase Sales and Growth (2012-2017)
Figure Nigeria Urokinase Sales and Growth (2012-2017)
Figure Egypt Urokinase Sales and Growth (2012-2017)
Figure Algeria Urokinase Sales and Growth (2012-2017)
Table Middle East Urokinase Sales by Manufacturer (2016-2017)
Figure Middle East Urokinase Sales Market Share by Manufacturer in 2016
Figure Middle East Urokinase Sales Market Share by Manufacturer in 2017
Table Middle East Urokinase Revenue by Manufacturer (2016-2017)
Figure Middle East Urokinase Revenue Market Share by Manufacturer in 2016
Figure Middle East Urokinase Revenue Market Share by Manufacturer in 2017
Table Middle East Urokinase Sales by Type (2012-2017)
Table Middle East Urokinase Sales Share by Type (2012-2017)
Table Middle East Urokinase Sales by Application (2012-2017)
Table Middle East Urokinase Sales Share by Application (2012-2017)
Table EMEA Urokinase Sales by Type (2012-2017)
Table EMEA Urokinase Sales Share by Type (2012-2017)
Table EMEA Urokinase Revenue by Type (2012-2017)
Table EMEA Urokinase Revenue Share by Type (2012-2017)
Figure EMEA Urokinase Powder Sales Growth (2012-2017)
Figure EMEA Urokinase Powder Price (2012-2017)
Figure EMEA Urokinase Solution Sales Growth (2012-2017)
Figure EMEA Urokinase Solution Price (2012-2017)
Table EMEA Urokinase Sales by Application (2012-2017)
Table EMEA Urokinase Sales Share by Application (2012-2017)
Figure EMEA Hospital Sales Growth (2012-2017)
Figure EMEA Clinic Sales Growth (2012-2017)
Figure EMEA Others Sales Growth (2012-2017)
Figure EMEA Urokinase Sales, Revenue and Growth Rate (2017-2022)
Table EMEA Urokinase Sales Forecast by Regions (2017-2022)
Table EMEA Urokinase Market Share Forecast by Regions (2017-2022)
Table Europe Urokinase Sales Forecast by Regions (2017-2022)
Figure Germany Urokinase Sales Forecast 2017-2022
Figure France Urokinase Sales Forecast 2017-2022
Figure UK Urokinase Sales Forecast 2017-2022
Figure Russia Urokinase Sales Forecast 2017-2022
Figure Italy Urokinase Sales Forecast 2017-2022
Figure Turkey Urokinase Sales Forecast 2017-2022
Table Middle East Sales Forecast by Regions (2017-2022)
Figure Saudi Arabia Urokinase Sales Forecast 2017-2022
Figure Israel Urokinase Sales Forecast 2017-2022
Figure UAE Urokinase Sales Forecast 2017-2022
Figure Iran Urokinase Sales Forecast 2017-2022
Table Africa Sales Forecast by Regions (2017-2022)
Figure South Africa Urokinase Sales Forecast 2017-2022
Figure Nigeria Urokinase Sales Forecast 2017-2022
Figure Egypt Urokinase Sales Forecast 2017-2022
Figure Algeria Urokinase Sales Forecast 2017-2022
Table EMEA Urokinase Sales Forecast by Type (2017-2022)
Table EMEA Urokinase Market Share Forecast by Type (2017-2022)
Table EMEA Urokinase Sales Forecast by Application (2017-2022)
Table EMEA Urokinase Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/ Dealers List